Australia Buys the World’s Largest Life Sciences Supercomputer



Loading...

By Allison Proffitt

June 14, 2010
| The Victoria Life Sciences Computation Initiative (VLSCI) in Victoria, Australia, has announced that it will have the world’s largest life sciences-dedicated supercomputer by 2012. The purchased IBM Blue Gene machine is expected to have around 64,000 cores, says Justin Zobel, professor of computer science and software engineering at the University of Melbourne, and head of the supercomputer project.

Zobel believes that a supercomputer of this power is essential to advancing life science research. “A machine of that size enables you to envision things you would not otherwise consider,” says Zobel. “It’s the exact opposite of [cloud computing]. The cloud is a very standardized computing resource available in a very flexible way at any scale depending on what you’re prepared to pay for…. But it doesn’t provide supercomputing. A bunch of computers in the same place is not the same as supercomputing.”

Zobel mentions “modeling organs based on a detailed simulation of the individual cells of the organ—such as the heart or brain,” as a potential project for the supercomputer, but the specifics are up to the researchers using the machine. “We want to see projects of that scale—things that are genuinely revolutionary—become enabled here in Victoria,” he says.

Victoria has more than 10,000 life sciences researchers based in the state capital at the University of Melbourne and at several other research institutes in the area. The Victorian government wanted to underpin some of the life sciences research going on in the state with a strong commitment to computing. In addition to partially funding the purchase of the supercomputer itself, the government set up the Victoria Life Sciences Computation Initiative.

|“What the VLSCI includes is a decent sized team of people, some of whom are IBM employees, some of whom are VLSCI employees, whose job it is to help life scientists make the best use of the machine,” explains Zobel.

The supercomputer itself will be housed in the Peak Computing Facility, the heart of the VLSCI. The PCF currently houses an SGI Altix with 3 racks, 1088 cores, and 10 teraflops that is in use. An IBM iDataPlex machine of 78 nodes capable of 6.6 teraflops has been delivered. The Blue Gene will come in two phases: a  Blue Gene/P 8192-core machine capable of 27 teraflops will arrive in a few weeks. The 2012 machine should be about 20 times that capacity. Once that supercomputer is delivered, the Blue Gene/P will be returned to IBM, but the iDataPlex and Altix machines will stay.

The VLSCI was announced two years ago, and the Initiative is staffed jointly by University of Melbourne researchers and IBM researchers. The university and IBM opened a collaborative laboratory in mid-February, which Zobel calls an outpost of IBM’s Watson Research Center.

Compute power on the supercomputer will be open to all Victoria-based researchers and subject to a grant process in which projects are granted compute time and support time based on scientific merit. The grant process is open now, and Zobel hopes to be creating user accounts on the Blue Gene/P by early August.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



bluearc_whitepaper0710
Breaking Through Real World Storage Barriers in Next Generation Sequencing
Sponsored by BlueArc

To effectively and efficiently manage the rapidly increasing needs of an NGS research environment numerous considerations for data management become important in moving today’s terabyte and petabyte levels of data. Some key concerns can include:

  • Maintaining enough  headroom to handle additional and unplanned data growth
  • How to address mixed workloads
  • Working with multiple file and network protocols
  • Dealing with aging data
  • Optimizing varied storage subsystems already in place while preparing for new floods of data to come

This paper investigates trends and solutions in addressing these issues, and more, for life science professionals.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series!

Covering a broad array of topics within the life sciences and drug development industries, these complimentary 90-minute web symposiums provide an interactive platform to learn more about cutting-edge bio-IT topics through expert analysis and discussions.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
Recorded on August 3, 2010
Sponsored by: Pegasystems
Program Details | Access Recording 

Next Gen Data Management for Next Gen Life Sciences
September 8, 2010 | 1:00pm - 2:30pm EST
Sponsored by Quantum
Program Details | Register Today 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.